Relationship of Pcna, C-Erbb2 and Cd44s Expression With Tumor Grade and Stage in Urothelial Carcinomas of the Bladder

dc.contributor.author Yildirim, Ayhan
dc.contributor.author Kosem, Mustafa
dc.contributor.author Sayar, Ilyas
dc.contributor.author Gelincik, Ibrahim
dc.contributor.author Yavuz, Alparslan
dc.contributor.author Bozkurt, Aliseydi
dc.contributor.author Bayram, Irfan
dc.date.accessioned 2025-05-10T16:57:35Z
dc.date.available 2025-05-10T16:57:35Z
dc.date.issued 2014
dc.description Yavuz, Alpaslan/0000-0002-8796-988X; Erkorkmaz, Unal/0000-0002-8497-4704 en_US
dc.description.abstract In the present study, the intention was to reveal the relationship of histological grade and stage with c-erbB2, CD44s, and PCNA immunoreactivity in bladder urothelial carcinomas (UC). In our study, we evaluated 46 items of transurethral resection material of patients submitted by YYU Faculty of Medicine, Main Department of Pathology, with a mass revealed in their bladder after clinical and radiological studies at our laboratories and who were diagnosed with urothelial carcinomas. PCNA, c-erbB2, and CD44s were applied in an immunohistochemical manner comprised from nine low-malignant potential papillary urothelial neoplasia, 23 low-grade papillary urothelial carcinoma, and 14 high-grade papillary urothelial carcinoma. Immunostaining was scored according to the percentage of positive cells. The immunohistochemical study demonstrated that the c-erbB2 and PCNA staining ratio increased when an increase occurred in stage and grade. The CD44s staining ratio decreased. C-erbB2, PCNA, and CD44s appear to be a useful marker in the assessment of the prognosis and treatment options in urothelial carcinomas. en_US
dc.identifier.issn 1940-5901
dc.identifier.scopus 2-s2.0-84904036546
dc.identifier.uri https://hdl.handle.net/20.500.14720/4108
dc.language.iso en en_US
dc.publisher E-century Publishing Corp en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Urothelial Carcinomas en_US
dc.subject Pcna en_US
dc.subject Cd44 en_US
dc.subject C-Erbb2 en_US
dc.subject Immunohistochemical Study en_US
dc.title Relationship of Pcna, C-Erbb2 and Cd44s Expression With Tumor Grade and Stage in Urothelial Carcinomas of the Bladder en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Yavuz, Alpaslan/0000-0002-8796-988X
gdc.author.id Erkorkmaz, Unal/0000-0002-8497-4704
gdc.author.scopusid 56260632400
gdc.author.scopusid 6603721364
gdc.author.scopusid 55945180700
gdc.author.scopusid 17134802600
gdc.author.scopusid 55682194900
gdc.author.scopusid 55755871000
gdc.author.scopusid 14622668400
gdc.author.wosid Yavuz, Alpaslan/H-3947-2014
gdc.author.wosid Kösem, Mustafa/Jce-7269-2023
gdc.author.wosid Yavuz, Alpaslan/E-2699-2014
gdc.author.wosid Erkorkmaz, Unal/Aaa-4241-2022
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Yildirim, Ayhan] Diyarbakir Pediat & Gynecol Hosp, Dept Pathol, Diyarbakir, Turkey; [Kosem, Mustafa] Sakarya Univ, Dept Pathol, Sakarya, Turkey; [Sayar, Ilyas] Erzincan Univ, Dept Pathol, Erzincan, Turkey; [Gelincik, Ibrahim] Namik Kemal Univ, Dept Pathol, Tekirdag, Turkey; [Yavuz, Alparslan] Yuzuncu Yil Univ, Dept Radiol, Van, Turkey; [Bozkurt, Aliseydi] Erzincan Univ, Dept Urol, Erzincan, Turkey; [Erkorkmaz, Unal] Sakarya Univ, Dept Biostat, Sakarya, Turkey; [Bayram, Irfan] Yuzuncu Yil Univ, Dept Pathol, Van, Turkey en_US
gdc.description.endpage 1523 en_US
gdc.description.issue 6 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality N/A
gdc.description.startpage 1516 en_US
gdc.description.volume 7 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality N/A
gdc.identifier.pmid 25035774
gdc.identifier.wos WOS:000341255900004
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files